Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$571.73 USD
-5.66 (-0.98%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $572.09 +0.36 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Income Statements
Fiscal Year end for Thermo Fisher Scientific Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 42,857 | 44,915 | 39,211 | 32,218 | 25,542 |
Cost Of Goods | 25,757 | 25,944 | 19,573 | 16,214 | 14,214 |
Gross Profit | 17,100 | 18,971 | 19,638 | 16,004 | 11,328 |
Selling & Adminstrative & Depr. & Amort Expenses | 10,241 | 10,578 | 9,610 | 8,210 | 6,734 |
Income After Depreciation & Amortization | 6,859 | 8,393 | 10,028 | 7,794 | 4,594 |
Non-Operating Income | 814 | 168 | -651 | -16 | 152 |
Interest Expense | 1,375 | 726 | 536 | 553 | 676 |
Pretax Income | 6,298 | 7,835 | 8,841 | 7,225 | 4,070 |
Income Taxes | 284 | 703 | 1,109 | 850 | 374 |
Minority Interest | -40 | 10 | 3 | 0 | 0 |
Investment Gains/Losses | -59 | -172 | -4 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 5,955 | 6,960 | 7,728 | 6,375 | 3,696 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 5,995 | 6,950 | 7,725 | 6,375 | 3,696 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 10,265 | 11,774 | 12,620 | 10,119 | 6,871 |
Depreciation & Amortization (Cash Flow) | 3,406 | 3,381 | 2,592 | 2,325 | 2,277 |
Income After Depreciation & Amortization | 6,859 | 8,393 | 10,028 | 7,794 | 4,594 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 388.00 | 394.00 | 397.00 | 399.00 | 403.00 |
Diluted EPS Before Non-Recurring Items | 21.55 | 23.24 | 25.13 | 19.55 | 12.35 |
Diluted Net EPS (GAAP) | 15.45 | 17.63 | 19.46 | 15.96 | 9.17 |
Fiscal Year end for Thermo Fisher Scientific Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 10,886.00 | 10,574.00 | 10,687.00 | 10,710.00 |
Cost Of Goods | NA | 6,493.00 | 6,258.00 | 6,436.00 | 6,570.00 |
Gross Profit | NA | 4,393.00 | 4,316.00 | 4,251.00 | 4,140.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2,539.00 | 2,452.00 | 2,673.00 | 2,577.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,854.00 | 1,864.00 | 1,578.00 | 1,563.00 |
Non-Operating Income | NA | 276.00 | 260.00 | 178.00 | 100.00 |
Interest Expense | NA | 390.00 | 359.00 | 326.00 | 300.00 |
Pretax Income | NA | 1,740.00 | 1,765.00 | 1,430.00 | 1,363.00 |
Income Taxes | NA | 133.00 | 53.00 | 52.00 | 46.00 |
Minority Interest | NA | -24.00 | -20.00 | 1.00 | 3.00 |
Investment Gains/Losses | NA | -1.00 | -17.00 | -16.00 | -25.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 1,606.00 | 1,695.00 | 1,362.00 | 1,292.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 1,630.00 | 1,715.00 | 1,361.00 | 1,289.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 388.00 | 388.00 | 388.00 | 388.00 |
Diluted EPS Before Non-Recurring Items | NA | 5.67 | 5.69 | 5.15 | 5.03 |
Diluted Net EPS (GAAP) | NA | 4.20 | 4.42 | 3.51 | 3.32 |